+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Compounding Pharmacy: Global Strategic Business Report

  • PDF Icon

    Report

  • 187 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309399
Description Jump to:

Global Compounding Pharmacy Market to Reach $17.7 Billion by 2030

The global market for Compounding Pharmacy estimated at US$12.4 Billion in the year 2022, is projected to reach a revised size of US$17.7 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2022-2030. Oral, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$7.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Topical segment is readjusted to a revised 4.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.7 Billion, While China is Forecast to Grow at 4.3% CAGR

The Compounding Pharmacy market in the U.S. is estimated at US$3.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 4.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 3.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Select Competitors (Total 27 Featured) -

  • B. Braun Melsungen AG
  • Dougherty's Pharmacy, Inc.
  • Fagron NV
  • Fresenius Kabi AG
  • Village Compounding Pharmacy
  • Wedgewood Pharmacy

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Compounding Pharmacy - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Rectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Rectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Rectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Ophthalmic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Ophthalmic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Ophthalmic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Nasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 24: World 16-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 25: World Compounding Pharmacy Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 26: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 27: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 28: World 16-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 29: World Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 30: World Historic Review for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 31: World 16-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 32: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 33: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 34: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 35: USA Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: USA Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 37: USA 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 38: USA Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: USA Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 40: USA 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
CANADA
  • Table 41: Canada Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: Canada Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 43: Canada 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 44: Canada Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Canada Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 46: Canada 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
JAPAN
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 47: Japan Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 48: Japan Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 49: Japan 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 50: Japan Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Japan Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 52: Japan 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
CHINA
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 53: China Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 54: China Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 55: China 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 56: China Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: China Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 58: China 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
EUROPE
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 59: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Compounding Pharmacy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 61: Europe 16-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 62: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: Europe Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 64: Europe 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 65: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 66: Europe Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 67: Europe 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
FRANCE
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 68: France Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: France Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 70: France 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 71: France Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 72: France Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 73: France 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
GERMANY
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 74: Germany Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 75: Germany Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 76: Germany 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 77: Germany Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 78: Germany Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 79: Germany 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
ITALY
  • Table 80: Italy Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 81: Italy Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 82: Italy 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 83: Italy Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 84: Italy Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 85: Italy 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 86: UK Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 87: UK Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 88: UK 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 89: UK Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 90: UK Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 91: UK 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 97: Rest of Europe 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
REST OF WORLD
  • Table 104: Rest of World Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 105: Rest of World Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 106: Rest of World 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2023 & 2030
  • Table 107: Rest of World Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 108: Rest of World Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 109: Rest of World 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • B. Braun Melsungen AG
  • Dougherty's Pharmacy, Inc.
  • Fagron NV
  • Fresenius Kabi AG
  • Village Compounding Pharmacy
  • Wedgewood Pharmacy

Table Information

Report AttributeDetails
No. of Pages187
PublishedApril 2024
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 12.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.7 Billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal

Related Topics

Related Reports

Global Compounding Pharmacy Market 2023-2027 - Product Image

Global Compounding Pharmacy Market 2023-2027

  • Report
  • 163 Pages
  • Global
From
Compounding Pharmacy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Compounding Pharmacy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Compounding Pharmacies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Compounding Pharmacies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 245 Pages
  • Global
Sterile Compounding Pharmacies Global Market Report 2024 - Product Image

Sterile Compounding Pharmacies Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Compounding Pharmacy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Compounding Pharmacy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 83 Pages
  • Global
From

About the Compounding Pharmacies Market

Compounding Pharmacies are a subset of Drugstores and Pharmacies that specialize in the preparation of customized medications. Compounding Pharmacies are able to create medications tailored to the specific needs of a patient, such as altering the dosage form, strength, or flavor of a medication. Compounding Pharmacies also offer medications that are not commercially available, such as those that are no longer manufactured or those that are not available in the desired dosage form. Compounding Pharmacies are regulated by the United States Pharmacopeia and the Food and Drug Administration. Compounding Pharmacies are often used by patients who have difficulty taking commercially available medications, such as those with allergies or sensitivities to certain ingredients. Compounding Pharmacies also provide medications for veterinary use, such as medications for animals that are not available commercially. Some companies in the Compounding Pharmacies market include Apothecary By Design, B&B Pharmaceuticals, and Wedgewood Pharmacy. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.